Healthcare
Medicine Man Technologies, Inc.(SHWZ)
Live Price
Offline$0.00001
+0.00% today
1Y Change
-99.55%
Window
Jun 23, 2025 โ Jun 12, 2026
- Market Cap
- โ
- Revenue Growth
- +8.2%
- EPS Growth
- +46.9%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Medicine Man Technologies, Inc. (SHWZ) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 99.5% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +8.2%, EPS growth of +46.9%, a dividend yield of 0.0%. What stands out right now is revenue +8.2%, EPS +46.9%, free cash flow +146.4% with operating margin 1.9% and ROIC 1.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Stock Foundry combines SHWZ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+8.2% vs +7.6% peer median
Operating Margin
Below sector median
+1.9% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +8.2% and EPS at +46.9%, with operating margin around 1.9%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +96.7% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | +0.0% | +0.0% | +0.0% |
2026 Mar 26, 2026 | โ | +900.0% | +0.0% | -90.0% |
2025 Aug 15, 2025 | โ | +125.0% | +290.0% | -99.9% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SHWZ
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SHWZ Max Drawdown
-100.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SHWZ and SPY.
Company Overview
Medicine Man Technologies, Inc.
Other OTC
Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes. As of March 14, 2022, it owned and operated 23 retail cannabis dispensaries under the Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift banner names in Denver and Colorado; and 10 medical retail cannabis dispensaries under the R. Greenleaf banner in New Mexico. The company also provides licensing and consulting, facility design, and facility management services; and Three A Light publication. In addition, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is headquartered in Denver, Colorado.
- Leadership
- Forrest Hoffmaster
- IPO Date
- Feb 16, 2018
- Employees
- 729
- Street Address
- 4880 Havana Street
- Mailing
- Denver, CO, 80239
- Region
- Denver, CO, US
- Reporting Currency
- USD
- Investor Line
- 303 371 0387
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 4.5
- Price/Sales
- 0.0
- Price/Book
- 0.0
Growth
- Revenue
- +8.2%
- EPS
- +46.9%
- Free Cash Flow
- +146.4%
Profitability
- Gross Margin
- 44.1%
- Operating Margin
- 1.9%
- Net Margin
- -20.0%
- ROE
- -27.5%
- ROIC
- 1.1%
Balance Sheet
- Debt/Equity
- 1.61
- Current Ratio
- 0.97
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.